Go Pro

Marker Therapeutics (MRKR) News Today

Marker Therapeutics logo
$1.50 +0.11 (+7.91%)
Closing price 08/24/2026 04:00 PM Eastern
Extended Trading
$1.46 -0.04 (-3.00%)
As of 08/24/2026 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Marker Therapeutics Latest News

Q3 EPS Forecast for Marker Therapeutics Boosted by Analyst
MRKR Q3 EPS Estimate Increased by Brookline Capital Markets
Brokers Issue Forecasts for MRKR FY2028 Earnings
Marker Therapeutics Sets Date for 2026 Annual Meeting
Marker Therapeutics, Inc. Common Stock (MRKR)
Marker Therapeutics (MRKR) Receives a Buy from Canaccord Genuity
Marker Therapeutics reports FY24 EPS ($1.19) vs ($1.59) last year
Marker Therapeutics initiated with a Buy at Canaccord
Marker Therapeutics initiated with a Buy at Brookline

Marker Therapeutics Media Mentions By Week

Marker Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRKR
News Sentiment

0.31

0.66

Average
Healthcare
News Sentiment

Marker Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRKR Articles
This Week

21

2

MRKR Articles
Average Week

Marker Therapeutics Trends on MarketBeat

This week vs. last week
Searches
1
-50%
Page Views
1,830
+8%
Get Marker Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Marker Therapeutics dated 8/22/2026.
From Our Partners